New Cream Targets Brain's Cannabinoid Receptors Without Using THC Or CBD

Detroit doctors Jessica and Rachel Kado launched CB2++ Repair Cream, a patented product that provides inflammation and pain relief by targeting the body's CB2 cannabinoid receptor. A plant-based, non-prescription cream, this product binds cannabinoid receptors without using THC or CBD.

CB2++ has been used by professional athletes including players from the Detroit Lions and is endorsed by Kevin Bastin, former NFL head athletic trainer for 25 years with the Lions, Houston Texans and Washington Redskins.

See Also: The 'Titleist Of CBD': Pro Golfer Scott McCarron Says CBD Oil Helped Him Win In 2019

“This is the next generation of care for anti-inflammation and pain relief,” Dr. Jessica Kado said. “Using non-marijuana plants, we have been able to harness the power of phytocannabinoids by targeting a receptor called CB2 that is naturally active in the body's immune system. The results have been outstanding in treating sore muscles, joints and tendons in repair, recovery and injury prevention in people of all ages. We are excited to launch our product commercially to a wider audience."

Bastin also weighed in on the product.

“To decrease skin and tendon inflammation quickly without using irritants or steroids, look no further than CB2++ repair cream. Using this product, we have seen positive results and the feedback from athletes has been universally positive,” Bastin said.

Want to hear exclusive updates on the adult-use licensing process? Check out the next meetup with MRA Executive Director, Andrew Brisbo on Dec. 18 at the Benzinga Headquarters! Get your tickets here before they sell out!

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.